Search Results - Layla Veleanu

  • Showing 1 - 2 results of 2
Refine Results
  1. 1

    De novo generation of the NPM-ALK fusion recapitulates the pleiotropic phenotypes of ALK+ ALCL pathogenesis and reveals the ROR2 receptor as target for tumor cells by Loélia Babin, Alice Darchen, Elie Robert, Zakia Aid, Rosalie Borry, Claire Soudais, Marion Piganeau, Anne De Cian, Carine Giovannangeli, Olivia Bawa, Charlotte Rigaud, Jean-Yves Scoazec, Lucile Couronné, Layla Veleanu, Agata Cieslak, Vahid Asnafi, David Sibon, Laurence Lamant, Fabienne Meggetto, Thomas Mercher, Erika Brunet

    Published in Molecular Cancer (2022-03-01)
    Get full text
    Article


  2. 2

    P1166: BRIGATINIB IN PATIENTS WITH ALK-POSITIVE ANAPLASTIC LARGE CELL LYMPHOMA WHO HAVE FAILED BRENTUXIMAB VEDOTIN by Layla Veleanu, Bruno Tesson, Laurence Lamant, Ambroise Marçais, Julie Bruneau, Sophie Kaltenbach, Chantal Brouzes, Charlotte Degoutte, Josquin Moraly, Patrick Villarese, Ludovic Lhermitte, Mehdi Latiri, Gregoire Hure, Adrien Chauchet, Caroline Delette, Sylvie Grosleron, Elise Toussaint, Quentin Cabrera, Pauline Brice, Francois-Xavier Gros, Aline Clavert, Lucie Oberic, Marielle Legoff, Sophie Cereja, Fabienne Meggetto, Elizabeth Macintyre, Vahid Asnafi, David Sibon

    Published in HemaSphere (2023-08-01)
    Get full text
    Article


Search Tools: